340 related articles for article (PubMed ID: 15767349)
1. Trends in cervical squamous cell carcinoma incidence in 13 European countries: changing risk and the effects of screening.
Bray F; Loos AH; McCarron P; Weiderpass E; Arbyn M; Møller H; Hakama M; Parkin DM
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):677-86. PubMed ID: 15767349
[TBL] [Abstract][Full Text] [Related]
2. Incidence trends of adenocarcinoma of the cervix in 13 European countries.
Bray F; Carstensen B; Møller H; Zappa M; Zakelj MP; Lawrence G; Hakama M; Weiderpass E
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2191-9. PubMed ID: 16172231
[TBL] [Abstract][Full Text] [Related]
3. The Icelandic and Nordic cervical screening programs: trends in incidence and mortality rates through 1995.
Sigurdsson K
Acta Obstet Gynecol Scand; 1999 Jul; 78(6):478-85. PubMed ID: 10376856
[TBL] [Abstract][Full Text] [Related]
4. Trends in cancer of the cervix uteri in Sweden following cytological screening.
Bergström R; Sparén P; Adami HO
Br J Cancer; 1999 Sep; 81(1):159-66. PubMed ID: 10487628
[TBL] [Abstract][Full Text] [Related]
5. Worldwide trends in cervical cancer incidence: impact of screening against changes in disease risk factors.
Vaccarella S; Lortet-Tieulent J; Plummer M; Franceschi S; Bray F
Eur J Cancer; 2013 Oct; 49(15):3262-73. PubMed ID: 23751569
[TBL] [Abstract][Full Text] [Related]
6. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
[TBL] [Abstract][Full Text] [Related]
7. Cervical cancer.
Beral V; Hermon C; Muñoz N; Devesa SS
Cancer Surv; 1994; 19-20():265-85. PubMed ID: 7534630
[TBL] [Abstract][Full Text] [Related]
8. Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention.
Bray F; Dos Santos Silva I; Moller H; Weiderpass E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1132-42. PubMed ID: 15894663
[TBL] [Abstract][Full Text] [Related]
9. The changing pattern of cervical cancer in Northern Ireland 1965-1989.
Robertson JH; Woodend B
Ulster Med J; 1992 Apr; 61(1):19-23. PubMed ID: 1621297
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of cancer of the cervix: global and national perspective.
Shanta V; Krishnamurthi S; Gajalakshmi CK; Swaminathan R; Ravichandran K
J Indian Med Assoc; 2000 Feb; 98(2):49-52. PubMed ID: 11016150
[TBL] [Abstract][Full Text] [Related]
11. Do testicular seminoma and nonseminoma share the same etiology? Evidence from an age-period-cohort analysis of incidence trends in eight European countries.
Bray F; Richiardi L; Ekbom A; Forman D; Pukkala E; Cuninkova M; Møller H
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):652-8. PubMed ID: 16614105
[TBL] [Abstract][Full Text] [Related]
12. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
13. Recent trends in incidence of cervical cancer in several regions of south-western Europe.
Raymond L; Ménégoz F; Fioretta G
Rev Epidemiol Sante Publique; 1995; 43(2):122-6. PubMed ID: 7732198
[TBL] [Abstract][Full Text] [Related]
14. A model of the differentiation and relative incidence of glandular versus squamous cell neoplasia of the uterine cervix: connection between incidence and etiology.
Leppäluoto PA
Acta Obstet Gynecol Scand; 2008; 87(8):800-3. PubMed ID: 18704774
[TBL] [Abstract][Full Text] [Related]
15. Incidence of cervical carcinoma in a high-risk, non-screened area results of a retrospective analysis on the Dutch Caribbean Antilles from 1983 to 1998.
Bax A; Voigt RR; Coronel CC; Putter H; de Bie Leuving Tjeenk RM; van Marwijk HW
West Indian Med J; 2004 Jun; 53(3):150-4. PubMed ID: 15352742
[TBL] [Abstract][Full Text] [Related]
16. Reduction in the cumulative incidence rate of cervical cancer by one life time selective screening.
Juneja A; Murthy NS; Tuteja RK; Sardana S; Das DK
Neoplasma; 1997; 44(4):272-4. PubMed ID: 9473783
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of cervical cancer in Taiwan.
Wang PD; Lin RS
Gynecol Oncol; 1996 Sep; 62(3):344-52. PubMed ID: 8812531
[TBL] [Abstract][Full Text] [Related]
18. Trends in cervical cancer survival in Europe, 1983-1994: a population-based study.
Bielska-Lasota M; Inghelmann R; van de Poll-Franse L; Capocaccia R;
Gynecol Oncol; 2007 Jun; 105(3):609-19. PubMed ID: 17399766
[TBL] [Abstract][Full Text] [Related]
19. The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri.
Nieminen P; Kallio M; Hakama M
Obstet Gynecol; 1995 Jun; 85(6):1017-21. PubMed ID: 7770247
[TBL] [Abstract][Full Text] [Related]
20. Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Extensive Screening Programme, 1985-2000.
Visioli CB; Zappa M; Ciatto S; Iossa A; Crocetti E
Cancer Detect Prev; 2004; 28(6):461-4. PubMed ID: 15582270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
